$MJNA news out yesterday! Great News! Post-Historic Address With Mexico's President, Activist Raúl Elizalde Meets Medical Marijuana, Inc. CEO, Discusses RSHO-X Federally Approved Import
http://finance.yahoo.com/news/post-historic-a...00988.html
SAN DIEGO, CA--(Marketwired - May 03, 2016) - After his participation in the Fourth National Debate for the Usage of Marijuana and his historic speech with Mexican President Peña Nieto, Raúl Elizalde, Founder of Por Grace (Por Todos), will hold a meeting with Dr. Stuart Titus, CEO of Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the U.S. Among the meeting discussion topics will be RSHO-X™, the first-ever cannabis product to receive approval from the federal government of Mexico for importation.
Dr. Titus states, "We are extremely impressed with Raul Elizalde's passion for the health and well-being of others around the world. In his speech at the final National Debate on the Usage of Marijuana in Mexico City, he specifically differentiates between the psychoactive forms of cannabis as opposed to non-psychoactive forms -- which includes industrial hemp-derived cannabidiol or 'CBD'. He noted to the audience that there is 'much work to be done' with changing laws about cannabis access in Mexico. However, that work has now received the blessing of Mexico's President Nieto."
The meeting with Dr. Titus and Elizalde will take place at Medical Marijuana, Inc. headquarters and will allow Elizalde to show the medical progress that his daughter, Grace Elizalde, has had after using (cannabidiol) CBD hemp oil for the treatment of seizures caused by Lennox Gastaut syndrome. Titus will update Elizalde on the work that Medical Marijuana, Inc. is doing in Latin America, and being the first company to receive approval from COFEPRIS (the Federal Commission for the Protection Against Sanitary Risks) to import RSHO-X™ into Mexico for families there.
"Medical Marijuana, Inc. was the first company to receive approval from COFEPRIS for our RSHO-X product, the first patients to receive it were Maria Paula and Alina Maldonado Montes de Oca, whose father Abelardo Maldonado Constantino rode eight hours -- one way-- by bus to pick up his import permit," Dr. Titus said. "We applaud the government of Mexico, in particular COFEPRIS, as well as the great work of Raúl Elizalde with the Por Grace foundation for helping to open up access to hemp CBD products such as RSHO-X™ to the people of Mexico."
The May 4th meeting allows Medical Marijuana, Inc. executives and Elizalde to collaborate on how to open up even greater access to the Company's hemp CBD-based products to the people of Mexico, and also discuss how to better educate health professionals and patients about recent studies and the U.S. Department of Health and Human Services' Patent 6,630,507 "Cannabinoids as Antioxidants and Neuroprotectants."
This alliance reinforces the commitment of Medical Marijuana, Inc. and its subsidiary company HempMeds® to promote the universal right to health for all residents in both the United States and Mexico, but also call for governments around the world to reform laws permitting access to cannabis.
http://finance.yahoo.com/news/post-historic-a...00988.html
SAN DIEGO, CA--(Marketwired - May 03, 2016) - After his participation in the Fourth National Debate for the Usage of Marijuana and his historic speech with Mexican President Peña Nieto, Raúl Elizalde, Founder of Por Grace (Por Todos), will hold a meeting with Dr. Stuart Titus, CEO of Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the U.S. Among the meeting discussion topics will be RSHO-X™, the first-ever cannabis product to receive approval from the federal government of Mexico for importation.
Dr. Titus states, "We are extremely impressed with Raul Elizalde's passion for the health and well-being of others around the world. In his speech at the final National Debate on the Usage of Marijuana in Mexico City, he specifically differentiates between the psychoactive forms of cannabis as opposed to non-psychoactive forms -- which includes industrial hemp-derived cannabidiol or 'CBD'. He noted to the audience that there is 'much work to be done' with changing laws about cannabis access in Mexico. However, that work has now received the blessing of Mexico's President Nieto."
The meeting with Dr. Titus and Elizalde will take place at Medical Marijuana, Inc. headquarters and will allow Elizalde to show the medical progress that his daughter, Grace Elizalde, has had after using (cannabidiol) CBD hemp oil for the treatment of seizures caused by Lennox Gastaut syndrome. Titus will update Elizalde on the work that Medical Marijuana, Inc. is doing in Latin America, and being the first company to receive approval from COFEPRIS (the Federal Commission for the Protection Against Sanitary Risks) to import RSHO-X™ into Mexico for families there.
"Medical Marijuana, Inc. was the first company to receive approval from COFEPRIS for our RSHO-X product, the first patients to receive it were Maria Paula and Alina Maldonado Montes de Oca, whose father Abelardo Maldonado Constantino rode eight hours -- one way-- by bus to pick up his import permit," Dr. Titus said. "We applaud the government of Mexico, in particular COFEPRIS, as well as the great work of Raúl Elizalde with the Por Grace foundation for helping to open up access to hemp CBD products such as RSHO-X™ to the people of Mexico."
The May 4th meeting allows Medical Marijuana, Inc. executives and Elizalde to collaborate on how to open up even greater access to the Company's hemp CBD-based products to the people of Mexico, and also discuss how to better educate health professionals and patients about recent studies and the U.S. Department of Health and Human Services' Patent 6,630,507 "Cannabinoids as Antioxidants and Neuroprotectants."
This alliance reinforces the commitment of Medical Marijuana, Inc. and its subsidiary company HempMeds® to promote the universal right to health for all residents in both the United States and Mexico, but also call for governments around the world to reform laws permitting access to cannabis.
